Norwell Consumer Healthcare Acquires Boyd Pharmaceuticals' Canadian OTC Brands

July 5, 2023

Norwell Consumer Healthcare Inc. has entered a definitive agreement to acquire a portfolio of assets from Boyd Pharmaceuticals, including the Colace, Colace Glycerin, Dequadin, Allenburys and Gelusil brands in Canada. The asset purchase strengthens Norwell's gastroenterology and cough & cold portfolio and supports accelerated growth of its consumer OTC business.

Buyers
Norwell Consumer Healthcare Inc.
Targets
Boyd Pharmaceuticals
Sellers
Boyd Pharmaceuticals
Industry
Pharmaceuticals
Location
Canada
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.